Showing results (151-160 of 166) with videos related to
Sort By:
Pageof 17
Leukemia|July 21, 2020
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemiaOliver Parting, Samantha Langer, Maja Kim Kuepper, et al.Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.Chemical Science|August 17, 2022
A pH-independent electrochemical aptamer-based biosensor supports quantitative, real-time measurement <i>in vivo</i>Shaoguang Li, Andrés Ferrer-Ruiz, Jun Dai, et al.Blood|January 15, 2016
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancyY Lucy Liu, Yan Yan, Cody Webster, et al.Stem Cell Research & Therapy|August 3, 2022
Irisin enhances chondrogenic differentiation of human mesenchymal stem cells via Rap1/PI3K/AKT axisTaiqiu Chen, Yan Peng, Wenjun Hu, et al.Science Translational Medicine|September 5, 2014
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemiaLeyuan Ma, Yi Shan, Robert Bai, et al.Cancer Discovery|September 16, 2016
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2Huafeng Xie, Cong Peng, Jialiang Huang, et al.Cancer Cell|July 19, 2002
Critical role for Gab2 in transformation by BCR/ABLMartin Sattler, M Golam Mohi, Yuri B Pride, et al.Nature Genetics|July 17, 2012
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cellsHaojian Zhang, Cong Peng, Yiguo Hu, et al.Oxidative Medicine and Cellular Longevity|August 2, 2022
Irisin Ameliorates Intervertebral Disc Degeneration by Activating LATS/YAP/CTGF SignalingTaiqiu Chen, Youxi Lin, Zizhao Wu, et al.Pageof 17